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Athletes with cardiac disorders frequently pose an ethical and medical dilemma to physicians 
assessing their eligibility to participate in sport. In recent decades, patient empowerment has 
been gaining increasing recognition in clinical decision-making. Empowerment is a process 
through which people are involved over the decisions and actions that affect their own lives. In 
the context of a cardiac disorder, empowerment means giving an athlete the chance to 
participate in the decision about whether or not to remain active in competition. Three models 
of treatment decision-making are described in this paper, with progressive levels of 
empowerment: the paternalistic model (the athlete has a passive role), the shared-decision 
making model (both athlete and physician participate in the decision) and the informed-
decision making (the decision is made by the athlete while the role of the physician is solely to 
provide information). This paper critically discusses the issues involved in disqualification of 
athletes with cardiovascular disorders and suggests possible ways of incorporating patient 
empowerment in potentially career-ending decisions. The authors propose a model of 
empowerment, which gives patients the opportunity to choose how much, and if, they would 
like to be involved in the decision-making process. 
 
 
Key-words: Shared decision-making; informed decision; paternalism; sudden cardiac death; 
cardiac disease; sport; arrhythmia. 
Abbreviations: SCD – sudden cardiac death; ICD – implantable cardioverter defibrillator; AED – 





The diagnosis of a cardiovascular disorder in a competitive athlete very frequently leads to the 
discontinuation of their sporting career due to concerns of disease progression and exercise-
induced sudden cardiac death (SCD) [1]. However, potential career-ending decisions are 
complex, associated with medical, ethical and legal challenges [2], and may result in significant 
psycho-social and economic adverse consequences for the athlete [3]. 
In recent decades, patient empowerment has been gaining increasing momentum in clinical 
decision-making [4]. In this paper we consider the issue of athletic disqualification in the full 
spectrum of cardiovascular disease, including cardiomyopathies, channelopathies, congenital 
heart disease, valvular heart disease, among others. Three subgroups of patients deserve 
additional considerations, besides the scope of this paper. Firstly, patients with structural 
conditions such as aortic stenosis, congenital coronary malformations and aortic aneurysms, 
due to their specific requirements, namely timely diagnosis and appropriate surgical 
correction. Secondly, patients with coronary artery disease as emphasis should be put on 
optimization of drug therapy, control of risk factors, and percutaneous or surgical 
revascularization. Lastly, athletes aged less than eighteen years pose specific challenges as 
they may not have the maturity or experience to weigh up these complex issues, they are 
subject to specific legal restrictions, and legal guardians should be involved in the decision-
process [5].  
 




1. To disqualify or not to disqualify? 
Disqualification of an athlete with an arrhythmic disorder poses an ethical challenge in that 
some will not have previous documentation of serious exercise-induced arrhythmia and do not 
have traditional risk markers (e.g. left ventricular dysfunction) [6]. Therefore, a physician 
assessing an athlete’s risk may face a dilemma: the athlete may have a condition which 
generally increases the risk for severe ventricular arrhythmia but specific high risk markers may 
be absent or not known (e.g. some individuals with inherited cardiomyopathy may have a mild 
phenotype and therefore may have a risk indistinguishable from the general population). On 
the other hand, by using the HCM risk-SCD risk prediction model, which has a c-statistic of only 
0.70, corresponding to moderate discrimination of risk of sudden cardiac death, the 5-year risk 
for individuals in the highest risk strata is still in the range of >6% over 5years [7], which means 
that for some of them, even if they were allowed to compete for 1 or 2 years, the chances of 
not experiencing an event are considerable. Other possible criticisms of the risk prediction 
model, which is still the best tool we have at the moment, reside in the fact that it still lacks 
validation in athletes. 
In some countries, even when doubt about any significant risk exists and this is estimated to be 
low, the decision to disqualify a person from sport is frequently made due to the potential for 
future lawsuits in the event of a life-changing (eg. hypoxic brain injury) or fatal outcome [5]. 
Even when this is not a motivating factor, the decision-making process in this context is heavily 
biased towards disqualification from a physician’s perspective. Physicians have little or nothing 
to lose personally by being conservative in their recommendations to disqualify athletes, 
whereas a less conservative approach poses a greater risk to their reputation and to personal 
feelings of guilt and shame if their athlete has a lethal event. Expert consensus guidance can 
help mitigate this risk of bias and facilitate informed decision-making.  
On the other hand, possible benefits or incentives to the physician by allowing a more active 
role of the athlete, and even sharing decisions, may be less clear. First, the physician should 
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acknowledge that athletes are human beings whose rights should be respected, and as such, 
they are currently entitled to have a word in their health-related decisions. Second, as 
disqualification in situations of unclear, or uncertain risk can very frequently have disastrous 
consequences to the individual, physicians should not want to have the onus of destroying 
individuals’ lives and dreams based on scarce evidence, fear of extremely unlikely arrhythmic 
events (which can now very often be successfully reverted by automatic external defibrillators 
– AEDs), and resistance to abandoning an old-fashioned and unethical paternalistic approach. 
Third, allowing athlete participation in the decision-process will enable the development of a 
more transparent relationship, with better collaboration, truth (avoiding omission of 
important facts while collecting clinical history) and exchange of information, avoiding the risk 
of “doctor shopping”. Paternalistic physicians should be aware that athletes may be prone to 
looking for more permissive physicians, instead of physicians with more expertise, who can 
give them clearer and better information and advice. Lastly, when athletes with “grey zone” 
cardiac conditions (where the risk is uncertain or not known) willingly accept a hypothetical 
risk, a close physician-athlete relationship will be of utmost importance to advance scientific 
knowledge in the area, and ascertain the true magnitude of risk and disease progression 
arising from exposure to competitive sports. Table 1 summarizes the main arguments relating 
to athlete empowerment. 
An intermediate path may constitute an appealing alternative to physicians not willing to 
follow this dichotomous approach (“to disqualify or not to disqualify”). To involve the athlete 
in a shared-decision comprising continuation of competition with an AED available, and under 
intensified monitoring through an implantable loop recorder, or an implantable cardioverter 
defibrillator if the patient meets guideline criteria, may be an option. Another fulfilling option 
for some athletes would be continuation of a different sport or in a less intensive way, or even 




2. What do the Experts say? 
Expert Consensus documents from two organisations exist for providing recommendations for 
sports practice in individuals with different cardiac abnormalities (the American Heart 
Association and American College of Cardiology 2015 scientific statement [8] and the Working 
group on Sports Cardiology of the European Society of Cardiology (ESC) consensus document 
[9]). However, strong evidence (if any) regarding most of the conditions was absent at the time 
of writing of the European document, and this is still an issue with the new American 
document, as it it is predominantly based on a consensus of expert opinion..  
Some of the recommendations appear to be inconsistent with current knowledge about some 
of these disorders. For example, most patients with hypertrophic cardiomyopathy will have a 
normal longevity and many do not develop severe ventricular arrhythmias [10]. A randomized 
controlled trial demonstrated that moderate-intensity exercise training was associated with a 
significant increase in exercise capacity, as measured through peak oxygen consumption, in 
individuals with hypertrophic cardiomyopathy [11]. This improvement occurred at the expense 
of no ventricular arrhythmia events.  However, guidelines are very restrictive for this group of 
patients if they have any phenotypic expression of the disease. Equally, the authors of the 
American consensus recognise the limitations of knowledge in this field stating- “Although this 
expert consensus report serves as a prudent guideline regarding sports eligibility or 
disqualification, there will always be tolerance in the system for some degree of flexibility, 
individual responsibility, and choice in making these decisions for individual student athlete-
patients”. Indeed for recently described entities, like isolated non-compaction of the left 
ventricle, which might affect as much as 8% of the athlete population [12], recommendations 
are absent in the European document [9], and in the new American consensus it is stated that, 
until more evidence is available, participation in competitive sports may be considered in the 
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absence of left ventricular systolic function impairment, or documented important atrial or 
ventricular arrhythmias, or unexplained syncope [13].  
Even though the new American scientific statement [14] is more liberal regarding 
channelopathies and supports participation under certain conditions, on the bases of recent 
findings [15, 16], the 2005 ESC recommendations [9] advise that these individuals should not 
be involved in competitive sports or should be excluded from most competitive sports, with 
the possibility of those of low intensity sports (Classification of sports is based on Mitchell et 
al. [17]).  
The changes in the recent update of the American recommendations illustrate how much 
knowledge in the field of risk stratification, technology (ICDs and AEDs), athlete’s heart and 
sports medicine has evolved in the last few years. However, there are still a lot of unknowns in 
the field, and the advice physicians can provide to athletes should by no means be regarded as 
definitive, reinforcing the need for regular assessment of these highly-trained individuals. 
 
3. Is there an effective treatment/prevention for sudden cardiac death? 
The results of the “National Registry for AED Use in Sports” confirmed the effectiveness of 
AEDs, providing support for these devices in strategic locations for the prevention of SCD 
during sports [18]. Analysis of arrests occurring during physical activity in this North American 
observational prospective study revealed that almost 90% of student athletes and adults who 
arrested during physical activity survived to hospital discharge. Witnessed arrests, and those 
happening in the setting of ventricular arrhythmia with cardioversion/defibrillation performed 
onsite had higher chances of survival to hospital discharge.  
A recent retrospective series of 291 children with long QT syndrome managed without ICDs 
supports the effectiveness of AEDs in this channelopathy, with 100% successful AED rescues 
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[19]. Events were rare (≈1%) during > 1,700 patient-years follow-up (i.e. <0.2 per 100 patient-
years). Only one out of the three events occurred during exercise, indicating that in 
appropriately treated patients these events are rare and sports restriction still leaves patients 
exposed to a low risk of life-threatening arrhythmia. 
Therefore, provision of AEDs is a key aspect to prevent SCD in patients without known cardiac 
disease, previous events or an indication for an ICD is now contemplated in the new American 
Heart Association and American College of Cardiology scientific statement -AEDs should be 
made available in sports, whether competition, training, practice, either in schools or other 
organizations hosting athletic events, or providing training facilities for organized competitive 
athletic programs [20]. 
However, some athletes may already have been implanted with an ICD. Should they be 
disqualified because of concerns regarding the implanted devices in competitive sports? The 
“ICD Sports Safety Registry” has provided very important preliminary data regarding this 
population [21]. No occurrence of tachyarrhythmic death, externally resuscitated 
tachyarrhythmia during or after sports, or severe injury resulting from arrhythmia-related 
syncope or shock during sports was observed in the 372 participants followed during a median 
of 31 months, suggesting that athletes can engage in sports without physical injury or failure of 
the ICD to terminate the arrhythmia.  
Accordingly, the new American Heart Association and American College of Cardiology scientific 
statement now allows the participation of athletes with ICDs in higher intensity sports if 
certain pre-requisites are met [22], suggesting progression into a more permissive approach 
across the Atlantic as knowledge in the subject grows and some of the previous concerns are 
not confirmed. However, if there are other reasons to restrict sports practice, like 
arrhythmogenic right ventricular cardiomyopathy with documented progression while in 
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competition, the recommendations state that ICD implantation should not be seen as a way to 
continue participation.  
 
II. Should the patient be involved in the decision? 
1.1 The concept of empowerment 
Empowerment is a widely used concept which can be generically defined as a process through 
which people who are disenfranchised gain more control over the decisions and actions that 
affect their own lives, acquire rights, decrease marginalization and achieve life goals [4, 23-25]. 
The verb “empower” means both “conceding power to others”, and “gaining or assuming 
power” [26]. A seminal definition of power was provided by Max Weber who stated that 
people have power when they can enforce their own will, even if others try to oppose them 
[27]. Empowerment can be measured as the “existence” of choice, the “use” of choice and the 
“achievement” of choice [28].  
 
1.2 Proposed model of empowerment for competitive athletes 
The process of empowerment requires a reformulation of the discrepancies in power between 
those who have it and those who do not [29]. According to Rappaport empowerment implies a 
relational dimension and means moving away from a paternalistic/controlling approach to a 
relationship that emphasizes people’s rights and responsibilities [29]. This is particularly 
relevant in health services, where empowerment involves a change in power-based 
relationships between the person who uses services and the health professional [30], where 
the first have a passive position and the latter exercises the power. Currently, the dominant 
medical approach towards competitive athletes may be considered paternalistic. Paternalism 
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is a pattern of behaviours, by a person or organization, which limits liberty or autonomy on an 
individual for that person’s or group’s own good, regardless of the will of the individual [31]. 
Chamberlin argues that having decision-making power and access to information are key 
elements of empowerment [32]. These two aspects are closely related since “decision-making 
shouldn’t happen in a vacuum. Decisions are best made when the individual has sufficient 
information to weigh the possible consequences of various choices” [32]. Thus, empowerment 
is closely related to choice. Prominent models of treatment decision-making have been 
described: a) the Paternalistic model, as described above, (places the patient in a passive role, 
a situation traditionally more acceptable in emergency situations); b) the Informed decision 
model (consisting of increasing a patient’s knowledge of therapeutic options and possible risks, 
so they can decide on their own, based on best scientific knowledge and their preferences); 
and c) the Shared decision-making model (where both patient and physician share their 
preferences, reach agreement, and share responsibility for the final decision) [33, 34]. A 
shared decision-making model for athletes has previously been suggested by Mitten: “ideally, 
the ultimate decision whether to participate in a sport with a cardiovascular abnormality 
should be the product of mutual agreement between the team physician, consulting 
cardiologists, team officials, the athlete...” [35].  
Implementation of an informed decision model is supported by John Stuart Mill's “On Liberty”: 
“the only purpose for which power can be rightfully exercised over any member of a civilized 
community, against his will is to prevent harm to others. His own good, either physical or 
moral, is not a sufficient warrant. Each is the proper guardian of his own health, whether 
bodily, or mental or spiritual” [31]. This opinion seems to be shared by Lampert et al. in a 
paper discussing sports participation in athletes with ICDs: “life is not risk-free, and ultimately 
an informed choice should lie with the individual athlete and his or her family” [36]. 
The role of society also needs to be taken into account as, in some circumstances, society can 
limit our freedom of choice, and we as members of society are expected to follow its rules, 
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moral, ethics, and law. It seems indisputable that we need to use a seatbelt while driving (and 
the law enforces us to do so) even though we are the only ones who may come to harm if we 
refuse to do it. However, other controversial themes like euthanasia, and abortion, raise the 
issue of how much freedom of choice an individual should be allowed and how much can 
society be allowed to choose on behalf of the individual. Also, this dilemma between “freedom 
of choice” and “freedom from society” may be subject to different interpretations for cultural 
reasons, which makes it almost impossible to achieve a universal solution for each problem. 
The same may also occur with empowerment. While the paternalistic approach might be 
construed as coercive, since the physician has total power for decision-making, the informed 
choice can also be perceived similarly if a patient declines the responsibility to choose. Forcing 
individuals to make a decision when they do not feel prepared can potentially be as coercive as 
imposing a decision. The shared decision-making model can also prove challenging when 
patient and physician cannot reach agreement. Decision is based on values, dreams, lifestyles 
and these are idiosyncratic. So, in the shared decision-making model physicians need to be 
careful in order to avoid imposing their own values system on the person they are treating. 
The model of empowerment we propose is not about placing the responsibility of decision on 
the patient (many patients do not want this responsibility), but rather giving patients the 
opportunity to choose which model of decision-making they prefer.  We conceptualize 
empowerment as giving patients the opportunity to choose how much they would like to be 
involved in the choice (which could be choosing not to choose and thus empowering the 
physician, shared-decision making or informed decision) (Figure 1). 
 
2. Can career-ending decisions result in severe consequences to the athlete? 
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A fundamental principle taught in medical schools is “primum non nocere”, first, do no harm. 
This implies that for an existing problem, the most important thing to do is to avoid worsening 
the condition (or more broadly, the person’s functioning) through treatment [37]. 
Disqualification of athletes may protect their physical health, but can induce harm in other 
ways and impact on psycho-social function [38]. Athletic retirement is often different from 
retirement in other occupations due to the age at which this typically happens and therefore 
the specific characteristics and problems associated with an athlete’s identity [39] and 
ambitions (the possibility of unmet goals and unfulfilled ambitions and objectives as players) 
[40, 41]. Patients with early or forced retirement fare worse, in terms of post-retirement 
adjustment and transition than those with control over the timing and circumstances of their 
retirement [39]. Furthermore, guidance and counselling are important if a patient needs to 
quit competition, as the decision should not be presented in an overdramatic or negative way. 
Not infrequently, athletes are highly driven individuals, determined to achieve their goals, and 
when they are still young, they may be fitted to change their career path if guidance is 
provided. On the other hand, professional athletes with lower levels of education and few 
professional skills to transfer to a non-sporting occupation, particularly if they have achieved 
higher visibility and earned large incomes, may struggle [42]. 
Negative outcomes resulting from disqualification include loss of identity, lack of perceived 
control, financial issues (reduction or loss of income and poverty), loss of social support from 
friends, sporting colleagues and fans [3], unemployment/unemployability, substance abuse, 
marital break-ups [43-45], depression and emotional adjustment difficulties [46]. 
Therefore, in situations where the risk of events is not expected to be high and if there is the 
possibility to establish necessary preventive measures, a premature and possibly unnecessary 
disqualification may do more harm than keeping an athlete in competition under closer 
surveillance. However, due to the sometimes rapid and unpredictable progression of these 
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heart rhythm disorders, sometimes things can go unexpectedly wrong even in low risk 
individuals, and fatalities, or cases of hypoxic brain injury, can occur. Sports clubs and 
organizations, athletes and relatives should be made fully aware of this possibility, and the 
necessary arrangements should be made to deal with and assume responsibility for these 
situations before and after they happen.  AEDs and trained personal should be available at all 
times, and a chain-of-action with appropriate acute medical management of arrhythmia and 
other cardiovascular issues should be arranged with rapid transfer to a hospital environment. 
 
3. The Fear of Disqualification 
When facing the possibility of an arrhythmic disorder, the fear of disqualification may lead the 
athlete/team into one of several situations: first, to try to hide or deny the severity of the 
clinical problem and arrange multiple consultations until the desired recommendation is 
obtained (known as “doctor shopping” [5]). The presence of contradictory opinions amongst 
experts can cause legal debates and confusion for a patient. Sometimes, only a single 
physician’s opinion may deviate from accepted or usual medical practice, while in others there 
may be a relatively equally split [35]. What should the decision be when dealing with 
conditions without evidence for treatment options and recommendations based on expert 
consensus? Which opinion and which experts should we value most? 
Second, strong economic interests may be involved in the dilemma, influenced by an athlete’s 
or team’s earning potential, rather than purely by a person’s health and safety [47]. In these 
circumstances, a great deal of pressure may be brought to bear on the treating physician and 
even the athlete against disqualification [1]. It should be clear, if empowerment is given to an 
athlete, whether the decision to accept competition is made out of free will, or only as a result 
of coercion by the sports team and family. However, differentiating between these two 
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situations may be difficult, and likely to require a lengthy and thorough discussion between the 
physician and athlete.  
Third, some situations may be transient and resolve after timely detection and appropriate 
intervention. Denying or hiding health problems (transparency should come first) can 
potentially lead to disastrous situations. 
Lastly, the physician may fear legal action as a result of a disqualification decision. Physicians 
may be liable for malpractice lawsuits if they deviate from professionally determined 
standards: failing to perform all appropriate diagnostic tests, not providing sufficiently clear 
information regarding medical risk associated with competitive athletic participation in 
patients with particular arrhythmic disorders and/or refusing to follow accepted guidelines for 
that scenario [35]. A written record regarding the discussion between the physician and 
athlete is of importance, but its legal value is uncertain in some countries. The issue of 
informed consent in athletes is discussed in detail elsewhere [48]. 
This area is made more contentious as guidelines are generally based on expert consensus as 
opposed to more robust randomised controlled trials (i.e. Class A evidence) and therefore, by 
their very nature, highly subjective. The particular experience of the guideline committee will 
heavily influence their published recommendation and guideline committees are usually 
populated by highly specialised physicians who are referred the most severe and most 
challenging cases. The country in which the physician practices will also heavily influence their 
views. Most guideline committees are based in American organizations and societies and 
American physicians typically work in a much more litigious environment than elsewhere in 
the world. However, it is important to stress that the recommendations do allow physicians to 
exercise their medical judgment in individual cases [8]. The American scientific statement 
recommendations do not, per se, rigidly restrict clinical practice or medical decision-making. A 
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clinician may still have the flexibility to suggest an alternative decision or strategy, deviating 
from the recommendations, if he believes it is in the best interest of a patient-athlete [6]  
 
III. Differences Across the Globe 
British law contemplates the concept of “volenti non fit injuria” (from Latin: "to a willing 
person, harm is not done") [49]. Applied to the athlete with a heart rhythm disorder, this 
would mean that if the athlete is willing to voluntarily expose himself to a risk, and if he fully 
knows and understands the extent of the possible consequences, there is no one he can blame 
in case something happens. The General Medical Council provides clear guidance in consenting 
patients and in the decision-making process, which seems to follow this premise [50]. 
Individuals with mental capacity to decide for themselves should be allowed to play the main 
role in the decision-making process, as discussed on point 5 of the document. This should 
happen irrespectively of the risk of adverse events, whether it is very low (annual risk deemed 
to be <1%), uncertain or high, as long as athletes can only harm themselves (i.e. if they are not 
placing other individuals at risk) with the decision of not abandoning their sporting career. In 
situations of a clearly life-threatening condition the physician can try to have a safeguarding 
role, but the ultimate decision should be allowed to the individual [50]. In the Good Medical 
Practice Document, issued by The General Medical Council, it is stated that doctors should 
“respect patients’ right to reach decisions with you about their treatment and care” [51]. 
While the United Kingdom has a more liberal approach [52], based on the informed-decision 
making model, some regions in Europe, tend to be often conservative, and paternalistic. For 
example, in the Veneto region in Italy, between 1982 and 2004, 879 out of 42,386 young 
athletes (2.1%) were disqualified from participation in competitive sports. Supra-ventricular 
arrhythmias, pericarditis, and hypertension were among the causes, and accounted for over 
40% of all cases [53]. This also contrasts with the liberal US approach. A survey carried out in 
16 
 
2006 members of the Heart Rhythm Society regarding sports participation in patients with an 
ICD, showed that avoidance of competitive sports was recommended by only less than half of 
the physicians [54]. Furthermore, Mayo Clinic pioneered a comprehensive shared-decision 
making process, which allows athletes with genetic heart diseases to return to play [55]. 
Among 246 assessed athletes, only 46 (19%) chose to quit sports. Preliminary data showed a 
low rate of cardiac events: one non-lethal event per 100 athlete-years in the whole cohort 
(which included pre-high school, high-school, college, recreational and professional athletes), 
and no cardiac events were observed at the post-high school level. Furthermore, one cardiac 
event also occurred in an athlete who ceased activity. These findings suggest that most 
athletes are willing to remain in competition, and that an increased level of athletic training 
may not correlate with a higher rate of cardiac events, thus supporting an empowering 
approach and the need of guideline re-evaluation. 
 
IV. Current Barriers and Suggestions for the Future  
The American guidelines have been recently updated and the European document should 
follow the same path in respect to the use of ICDs and AEDs in this population, management of 
low risk individuals with non-compaction of the left ventricle, and long QT syndrome, following 
the recent publication of a position paper by the European Heart Rhythm Association (EHRA), 
European Association of Preventive Cardiology, endorsed by the Heart Rhythm Society, 
Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología, and Asia Pacific Heart 
Rhythm Society on pre-participation screening [56]. However, models of patient 
empowerment to make decisions regarding level of activity and sports participation have not 
yet been included in the 2005 European consensus or in the recent American scientific 
statement. Interestingly, these concepts are slowly making their way into the arrhythmia field. 
A recent consensus document on patient’s values and preferences for the management of 
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cardiac tachyarrhythmias was recently published by the EHRA, and the concepts of shared-
decision making and informed decision were mentioned in this document, but only in the 
setting of atrial fibrillation (decisions towards rhythm or rate control and regarding oral 
anticoagulation) or management of distress in patients with ICDs [57]. Patient-centred care, 
education, and shared-decision making are also contemplated for the first time in the recent 
ESC atrial fibrillation guidelines, with an emphasis on addressing the needs, values and 
preferences of the patient [58]. The aforementioned approach by Mayo Clinic with the 
implementation of a Shared-Decision approach [55] is also a big step to be acknowledged and 
followed by other centres. 
Empowerment in this field will always face the challenge of uncertainty, how much risk is 
acceptable for the athlete to be exposed to, and a deeply rooted physician paternalistic 
behaviour. While moving from a paternalistic approach into a model where the patient has all 
the liberty to make choices is least likely to be considered in the presence of situations of very 
high risk or that are worsened by competitive, some physicians may already be more prone to 
adopting a shared decision making stance regarding situations where the risk is not that well 
established or even uncertain. 
Some situations deserve special attention as potential exceptions to patient empowerment. It 
is hard to draw a line and predict accurately which patients face imminent risk of life-
threatening cardiac events if allowed to compete. Furthermore, in sports like auto-racing, 
motorcycling or riflery, sudden cardiac arrest or an arrhythmic event may place the patient and 
other athletes or spectators at risk of physical injury. In these cases, the threshold for 
disqualifying an athlete must be substantially lower, because athletes should only be 
empowered and be free to place themselves at risk.  
We suggest the following as possible limits to patient empowerment or situations of very high 
risk where the athlete should be discouraged from pursuing a sports career: (a) risk of harm to 
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other individuals; (b) individuals without mental capacity to decide for themselves; (c) 
individuals whose the interference of third parties (relatives, sports club/organization) might 
affect their freedom to make an individual decision; (d) risk of direct and life-threatening harm 
resulting from loss of consciousness (i.e. fall from great height, drowning, heavy body or 
cranial trauma) in the evidence of a very high probability of arrhythmic events during 
competition; (e) need for temporary removal from competition due to a potentially reversible 
condition with highly likely benefit for the athlete resulting from temporary cessation of sports 
practice; (f) documentation of exercise/catecholaminergic driven life-threatening sustained 
ventricular arrhythmias in patients already on maximal β-blocker dose; (g) obstructive 
hypertrophic cardiomyopathy with severe dynamic gradient requiring appropriate intervention 
or (h) athletes previously requiring defibrillation during competition, namely if concerns exist 
regarding possible refractoriness or resistance of the arrhythmia and the availability of 
defibrillators.  
Some patients are willing to assume the risks resulting from competitive sports even if it 
includes the possibility of death [2]. As we propose a patient-centred care model, we suggest it 
is up to the patient to determine what brings quality and what is important to his or her life. If 
livelihood is the question, which is frequently the case in professional athletes [59]- is the 
ability of maintaining income considered reason enough to prevail over health concerns and 
safety? 
Paradoxically, there are sports like mountain climbing, auto-racing or extreme sports that 
place an individual at very high levels of physical risk in the absence of arrhythmic disorders or 
other health problems and these participants are still allowed to assume this risk without a 
paternalistic pressure from the society for safeguarding them [2]. If these individuals are 
permitted freedom to make their own risk-analysis decision on participating in these pastimes, 
why not the athlete with an arrhythmic disorder? 
19 
 
The question of how much liberty an athlete should have and what is the maximum level of 
risk they may be allowed to assume when making this decision, or which situations can be 
classified as too high risk, is still open for debate [59], and may differ among different 
countries. However, certain athletes with arrhythmic disorders could eventually be considered 
eligible for sports practice, assuming their conditions are considered stable, the necessary 
preventive measures are established (either ICDs or AEDs and trained personnel) and patients 
and sports organisations/teams are willing to take the risk to pursue their dream and assuming 
their choice doesn’t place any others at risk (See Figure 2). This should be regarded as a 
principle of liberty and personal choice that all of us should respect provided the athlete is 
truly expressing freewill independent of any coercive influences. We believe the deleterious 
effects on an individual’s personal, professional and psychological well-being should be taken 
into account in revised recommendations. They should also reflect the importance of sports in 
motivating these individuals and the conflict that exists between a traditionally paternalistic 
medical community, an ambiguous and currently mostly unsupportive legal framework and a 
dynamic public perception of individual choice and risk. Can we deny this choice based solely 
on a possibility, or potential risk of an event that may never occur and even if it does, can now 
be effectively managed in most circumstances? The calibration of risk to the athlete requires 
careful consultation between the athlete, physician and sports team/organisation as well as 
the athlete’s family. This decision & its basis must also be fully documented and recorded for 
medico-legal purposes with the athlete willing to accept responsibility for the management of 
his/her condition and associated risks. 
 
Conclusions 
The concept of empowerment in the assessment of eligibility of athletes with arrhythmic 
disorders has been clearly underexplored. The freedom of the individual should be respected 
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and an athlete’s will and freedom of choice should prevail over possible physical or 
psychological injury arising from prolonged sports practice or restriction in a significant 
number of cases. 
So far, the field of arrhythmic disorders has been a disempowering setting where the athlete 
has little or no say regarding medical decisions in their sporting career. This article proposes an 
empowerment approach, where the patients are not forced to decide, but are granted that 
possibility. Most people are used to a traditional, paternalistic approach in medicine where 
they have limited responsibility to decide and we expect many patients will still not want this 
responsibility. However, we also expect that many, particularly young people, will want to 
exercise their own choice. Future research needs to assess the extent to which people with 
these conditions would like to be involved in this type of decision. 
We believe that empowering the athlete may have several advantages including respect for 
people’s rights, a person-centred care approach, transparency and avoidance of “doctor 
shopping”. Ultimately, this will hopefully avoid denial of life-threatening heart conditions, 
forging a closer relationship between the athlete and specialized health-services and possibly 
improving the availability of care and chances of survival if a serious event occurs during 
competition. 
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Figure 1 – Proposed model for the empowerment of athletes with arrhythmic cardiac 
conditions. 
 
Note: * in some countries the ultimate decision should be allowed to the individual even if the 




Figure 2 – Authors’ suggested approach to Athlete Empowerment according to perceived risk 
of ventricular arrhythmias. 
 
Legend: CPVT – cathecolaminergic polimorphic ventricular tachycardia; HCM – hypertrophic 
cardiomyopathy; VT – ventricular tachycardia; VF – ventricular fibrillation; ARVC – 
arrhythmogenic right ventricular cardiomyopathy; EF – ejection fraction; LQTS – Long QT 
Syndrome; ICD – Implantable Cardioverter Defibrillator; DCM – Dilated Cardiomyopathy; LVNC 
– Left Ventricular Non-Compaction; VA – Ventricular Arrhythmias. Note: Arrhythmic risk on 







Table 1 – Main arguments regarding athlete empowerment from the Physician’s perspective. 
Benefits of Empowerment Possible Drawbacks 
 Respecting Athletes’ Liberty as human 
beings 
 Concern that athlete’s decision may not follow 
the Expert Consensus / Recommendations 
 Avoid destroying athletes’ 
professional lives and dreams 
 Risk to reputation or personal feelings if the 
athlete has an arrhythmic event 
 More transparent doctor-patient 
relationship, with better collaboration 
and truth 
 Fear of liability 
 Avoiding “doctor-shopping” – athletes 
will seek experts in the area instead of 
more permissive physicians 
 
 Acquiring more knowledge on “grey 
zone areas” if athletes are allowed to 
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